Logo image of CC

CHEMOURS CO/THE (CC) Stock Fundamental Analysis

NYSE:CC - US1638511089 - Common Stock

15.07 USD
-0.16 (-1.05%)
Last: 8/28/2025, 7:00:00 PM
15.08 USD
+0.01 (+0.07%)
After Hours: 8/28/2025, 7:00:00 PM
Fundamental Rating

3

Overall CC gets a fundamental rating of 3 out of 10. We evaluated CC against 84 industry peers in the Chemicals industry. CC may be in some trouble as it scores bad on both profitability and health. CC is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CC was profitable.
CC had a positive operating cash flow in the past year.
CC had positive earnings in 4 of the past 5 years.
Of the past 5 years CC 4 years had a positive operating cash flow.
CC Yearly Net Income VS EBIT VS OCF VS FCFCC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

CC's Return On Assets of -5.61% is on the low side compared to the rest of the industry. CC is outperformed by 70.24% of its industry peers.
Looking at the Return On Equity, with a value of -177.22%, CC is doing worse than 90.48% of the companies in the same industry.
The Return On Invested Capital of CC (1.19%) is worse than 73.81% of its industry peers.
Industry RankSector Rank
ROA -5.61%
ROE -177.22%
ROIC 1.19%
ROA(3y)1.94%
ROA(5y)3.39%
ROE(3y)11.39%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
CC Yearly ROA, ROE, ROICCC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

In the last couple of years the Profit Margin of CC has declined.
With a Operating Margin value of 1.68%, CC is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
CC's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 18.25%, CC is not doing good in the industry: 69.05% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CC has remained more or less at the same level.
Industry RankSector Rank
OM 1.68%
PM (TTM) N/A
GM 18.25%
OM growth 3Y-9.74%
OM growth 5Y0.08%
PM growth 3Y-46.26%
PM growth 5YN/A
GM growth 3Y-2.93%
GM growth 5Y0.69%
CC Yearly Profit, Operating, Gross MarginsCC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CC is destroying value.
Compared to 1 year ago, CC has more shares outstanding
The number of shares outstanding for CC has been reduced compared to 5 years ago.
CC has a worse debt/assets ratio than last year.
CC Yearly Shares OutstandingCC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CC Yearly Total Debt VS Total AssetsCC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CC has an Altman-Z score of 1.45. This is a bad value and indicates that CC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.45, CC is not doing good in the industry: 69.05% of the companies in the same industry are doing better.
CC has a Debt/Equity ratio of 17.31. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 17.31, CC is doing worse than 92.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 17.31
Debt/FCF N/A
Altman-Z 1.45
ROIC/WACC0.15
WACC8.04%
CC Yearly LT Debt VS Equity VS FCFCC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

CC has a Current Ratio of 1.68. This is a normal value and indicates that CC is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.68, CC is not doing good in the industry: 65.48% of the companies in the same industry are doing better.
A Quick Ratio of 0.83 indicates that CC may have some problems paying its short term obligations.
The Quick ratio of CC (0.83) is worse than 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 0.83
CC Yearly Current Assets VS Current LiabilitesCC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The earnings per share for CC have decreased strongly by -25.61% in the last year.
CC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.51% yearly.
CC shows a small growth in Revenue. In the last year, the Revenue has grown by 2.48%.
The Revenue has been growing slightly by 0.91% on average over the past years.
EPS 1Y (TTM)-25.61%
EPS 3Y-32.82%
EPS 5Y-13.51%
EPS Q2Q%52.63%
Revenue 1Y (TTM)2.48%
Revenue growth 3Y-3.05%
Revenue growth 5Y0.91%
Sales Q2Q%5.01%

3.2 Future

The Earnings Per Share is expected to grow by 30.08% on average over the next years. This is a very strong growth
Based on estimates for the next years, CC will show a small growth in Revenue. The Revenue will grow by 3.66% on average per year.
EPS Next Y4.75%
EPS Next 2Y33.93%
EPS Next 3Y30.08%
EPS Next 5YN/A
Revenue Next Year2.31%
Revenue Next 2Y3.47%
Revenue Next 3Y3.66%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CC Yearly Revenue VS EstimatesCC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
CC Yearly EPS VS EstimatesCC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

CC is valuated correctly with a Price/Earnings ratio of 12.35.
80.95% of the companies in the same industry are more expensive than CC, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.17, CC is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 6.94, the valuation of CC can be described as very cheap.
CC's Price/Forward Earnings ratio is rather cheap when compared to the industry. CC is cheaper than 92.86% of the companies in the same industry.
CC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.78.
Industry RankSector Rank
PE 12.35
Fwd PE 6.94
CC Price Earnings VS Forward Price EarningsCC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.6
CC Per share dataCC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CC does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CC's earnings are expected to grow with 30.08% in the coming years.
PEG (NY)2.6
PEG (5Y)N/A
EPS Next 2Y33.93%
EPS Next 3Y30.08%

5

5. Dividend

5.1 Amount

CC has a Yearly Dividend Yield of 2.47%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.54, CC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, CC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.47%

5.2 History

The dividend of CC has a limited annual growth rate of 0.25%.
CC has paid a dividend for at least 10 years, which is a reliable track record.
As CC did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)0.25%
Div Incr Years0
Div Non Decr Years8
CC Yearly Dividends per shareCC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

CC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-29.52%
EPS Next 2Y33.93%
EPS Next 3Y30.08%
CC Yearly Income VS Free CF VS DividendCC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

CHEMOURS CO/THE

NYSE:CC (8/28/2025, 7:00:00 PM)

After market: 15.08 +0.01 (+0.07%)

15.07

-0.16 (-1.05%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners98.72%
Inst Owner Change7.09%
Ins Owners0.44%
Ins Owner Change14.41%
Market Cap2.26B
Analysts74.44
Price Target15.43 (2.39%)
Short Float %9.99%
Short Ratio3.23
Dividend
Industry RankSector Rank
Dividend Yield 2.47%
Yearly Dividend0.99
Dividend Growth(5Y)0.25%
DP-29.52%
Div Incr Years0
Div Non Decr Years8
Ex-Date08-15 2025-08-15 (0.0875)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.69%
Min EPS beat(2)-40.66%
Max EPS beat(2)23.28%
EPS beat(4)2
Avg EPS beat(4)2.8%
Min EPS beat(4)-40.66%
Max EPS beat(4)36.8%
EPS beat(8)4
Avg EPS beat(8)6.59%
EPS beat(12)6
Avg EPS beat(12)5.91%
EPS beat(16)9
Avg EPS beat(16)9.91%
Revenue beat(2)1
Avg Revenue beat(2)-0.8%
Min Revenue beat(2)-1.79%
Max Revenue beat(2)0.19%
Revenue beat(4)2
Avg Revenue beat(4)-0.29%
Min Revenue beat(4)-1.79%
Max Revenue beat(4)1.08%
Revenue beat(8)3
Avg Revenue beat(8)-1.34%
Revenue beat(12)6
Avg Revenue beat(12)-0.73%
Revenue beat(16)9
Avg Revenue beat(16)0.14%
PT rev (1m)-1.63%
PT rev (3m)-26.93%
EPS NQ rev (1m)-49.63%
EPS NQ rev (3m)-57.22%
EPS NY rev (1m)-20.05%
EPS NY rev (3m)-25.41%
Revenue NQ rev (1m)-4.01%
Revenue NQ rev (3m)-3.22%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)0.17%
Valuation
Industry RankSector Rank
PE 12.35
Fwd PE 6.94
P/S 0.38
P/FCF N/A
P/OCF 8.74
P/B 9.52
P/tB 11.94
EV/EBITDA 13.6
EPS(TTM)1.22
EY8.1%
EPS(NY)2.17
Fwd EY14.4%
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)1.72
OCFY11.44%
SpS39.27
BVpS1.58
TBVpS1.26
PEG (NY)2.6
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.61%
ROE -177.22%
ROCE 1.76%
ROIC 1.19%
ROICexc 1.31%
ROICexgc 1.32%
OM 1.68%
PM (TTM) N/A
GM 18.25%
FCFM N/A
ROA(3y)1.94%
ROA(5y)3.39%
ROE(3y)11.39%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-17.6%
ROICexcg growth 5Y-0.48%
ROICexc growth 3Y-17.16%
ROICexc growth 5Y0.07%
OM growth 3Y-9.74%
OM growth 5Y0.08%
PM growth 3Y-46.26%
PM growth 5YN/A
GM growth 3Y-2.93%
GM growth 5Y0.69%
F-Score2
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 17.31
Debt/FCF N/A
Debt/EBITDA 9.43
Cap/Depr 92.86%
Cap/Sales 5.31%
Interest Coverage 250
Cash Conversion 59.31%
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 0.83
Altman-Z 1.45
F-Score2
WACC8.04%
ROIC/WACC0.15
Cap/Depr(3y)115.21%
Cap/Depr(5y)103.29%
Cap/Sales(3y)5.63%
Cap/Sales(5y)5.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25.61%
EPS 3Y-32.82%
EPS 5Y-13.51%
EPS Q2Q%52.63%
EPS Next Y4.75%
EPS Next 2Y33.93%
EPS Next 3Y30.08%
EPS Next 5YN/A
Revenue 1Y (TTM)2.48%
Revenue growth 3Y-3.05%
Revenue growth 5Y0.91%
Sales Q2Q%5.01%
Revenue Next Year2.31%
Revenue Next 2Y3.47%
Revenue Next 3Y3.66%
Revenue Next 5YN/A
EBIT growth 1Y-71.14%
EBIT growth 3Y-12.49%
EBIT growth 5Y0.99%
EBIT Next Year89.61%
EBIT Next 3Y34.53%
EBIT Next 5YN/A
FCF growth 1Y-146.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.98%
OCF growth 3YN/A
OCF growth 5YN/A